Publications - Aminah Jatoi, M.D.

Back to research profile

  1. Torres ML, Hartmann LC, Cliby WA, Kalli KR, Young PM, Weaver AL, Langstraat CL, Jatoi A, Kumar S, Mariani A. Nutritional status, CT body composition measures and survival in ovarian cancer. Gynecol Oncol. 2013 Jun; 129(3):548-53. Epub 2013 Mar 21.
    View PubMed
  2. Breitkopf CR, Stephens EK, Jatoi A. Hospice in End-of-Life Patients With Cancer: Does It Lead to Changes in Nonhospice Health Care Utilization After Stopping Cancer Treatment? Am J Hosp Palliat Care. 2013 May 10. [Epub ahead of print]
    View PubMed
  3. Feely MA, Collins CS, Daniels PR, Kebede EB, Jatoi A, Mauck KF. Preoperative testing before noncardiac surgery: guidelines and recommendations. Am Fam Physician. 2013 Mar 15; 87(6):414-8.
    View PubMed
  4. Stauder MC, Romero Y, Kabat B, Atherton PJ, Geno D, Deschamps C, Jatoi A, Sloan JA, Botros M, Jung KW, Arora AS, Miller RC, EABE Registry. Overall survival and self-reported fatigue in patients with esophageal cancer. Support Care Cancer. 2013 Feb; 21(2):511-9. Epub 2012 Jul 29.
    View PubMed
  5. Jatoi A, Allred JB, Suman VJ, Creagan ET, Croghan GA, Amatruda T, Markovic SN. Is Age >/= 70 Years an Important Predictor of Adverse Events Among Patients Enrolled in Metastatic Melanoma Trials? Findings from Pooled Analyses of Therapeutic Trials. J Geriatr Oncol. 2012 Oct 1; 3(4):307-11. Epub 2012 May 7
    View PubMed
  6. Ramiscal JA, Jatoi A. Nasal septal perforation from bevacizumab: a discussion of outcomes, management, and pharmacovigilance. Curr Oncol Rep. 2012 Aug; 14(4):307-10.
    View PubMed
  7. Atherton PJ, Burger KN, Loprinzi CL, Neben Wittich MA, Miller RC, Jatoi A, Sloan JA. Using the Skindex-16 and Common Terminology Criteria for Adverse Events to assess rash symptoms: results of a pooled-analysis (N0993). Support Care Cancer. 2012 Aug; 20(8):1729-35. Epub 2011 Sep 16.
    View PubMed
  8. Chen J, Qi Y, Wampfler JA, Jatoi A, Garces YI, Busta AJ, Mandrekar SJ, Yang P. Effect of cigarette smoking on quality of life in small cell lung cancer patients. Eur J Cancer. 2012 Jul; 48(11):1593-601. Epub 2012 Jan 12.
    View PubMed
  9. Jatoi A. Adjuvant chemotherapy and targeted therapy in elderly non-small-cell lung cancer patients. Aging health. 2012 Jun 1; 8(3):309-16.
    View PubMed
  10. Poterucha T, Burnette B, Jatoi A. A decline in weight and attrition of muscle in colorectal cancer patients receiving chemotherapy with bevacizumab. Med Oncol. 2012 Jun; 29(2):1005-9. Epub 2011 Mar 12.
    View PubMed
  11. Breitkopf CR, Egginton JS, Naessens JM, Montori VM, Jatoi A. Who is counseled to lose weight? Survey results and anthropometric data from 3,149 lower socioeconomic women. J Community Health. 2012 Feb; 37(1):202-7.
    View PubMed
  12. Yang P, Cheville AL, Wampfler JA, Garces YI, Jatoi A, Clark MM, Cassivi SD, Midthun DE, Marks RS, Aubry MC, Okuno SH, Williams BA, Nichols FC, Trastek VF, Sugimura H, Sarna L, Allen MS, Deschamps C, Sloan JA. Quality of life and symptom burden among long-term lung cancer survivors. J Thorac Oncol. 2012 Jan; 7(1):64-70.
    View PubMed
  13. Yang P, Kulig K, Boland JM, Erickson-Johnson MR, Oliveira AM, Wampfler J, Jatoi A, Deschamps C, Marks R, Fortner C, Stoddard S, Nichols F, Molina J, Aubry MC, Tang H, Yi ES. Worse disease-free survival in never-smokers with ALK+ lung adenocarcinoma. J Thorac Oncol. 2012 Jan; 7(1):90-7.
    View PubMed
  14. Jatoi A, Nieva JJ, Qin R, Loprinzi CL, Wos EJ, Novotny PJ, Moore DF Jr, Mowat RB, Bechar N, Pajon ER Jr, Hartmann LC. A pilot study of long-acting octreotide for symptomatic malignant ascites. Oncology. 2012; 82(6):315-20. Epub 2012 May 10.
    View PubMed
  15. Varkey P, Jatoi A, Williams A, Mayer A, Ko M, Files J, Blair J, Hayes S. The positive impact of a facilitated peer mentoring program on academic skills of women faculty. BMC Med Educ. 2012; 12:14 Epub 2012 Mar 23.
    View PubMed
  16. Stephens EK, Nguyen PL, Radecki Breitkopf C, Jatoi A. Former military officers from the Republic of Vietnam now living in the united states (US): exploring their perceptions of the US healthcare system. J Community Health. 2011 Dec; 36(6):992-8.
    View PubMed
  17. Jatoi A, Qi Y, Wampfler JA, Busta AJ, Yang P, Mandrekar S. The purported effects of alcohol on appetite and weight in lung cancer patients. Nutr Cancer. 2011 Nov; 63(8):1251-5. Epub 2011 Oct 14.
    View PubMed
  18. Coleman S, Kovtun I, Nguyen PL, Pittelkow M, Jatoi A. A qualitative study of the ramifications of rash from epidermal growth factor receptor (EGFR) inhibitors. Psychooncology. 2011 Nov; 20(11):1246-9. Epub 2010 Sep 23.
    View PubMed
  19. Jatoi A, Dakhil SR, Sloan JA, Kugler JW, Rowland KM Jr, Schaefer PL, Novotny PJ, Wender DB, Gross HM, Loprinzi CL, North Central Cancer Treatment Group. Prophylactic tetracycline does not diminish the severity of epidermal growth factor receptor (EGFR) inhibitor-induced rash: results from the North Central Cancer Treatment Group (Supplementary N03CB). Support Care Cancer. 2011 Oct; 19(10):1601-7. Epub 2010 Sep 06.
    View PubMed
  20. Coleman S, Peethambaram PP, Jatoi A. Consumer beware: a systematic assessment of potential bias in the lay electronic media to examine the portrayal of "PARP" inhibitors for cancer treatment. J Cancer Educ. 2011 Sep; 26(3):474-7.
    View PubMed
  21. Jatoi A. How important is palliative care? Curr Oncol Rep. 2011 Aug; 13(4):252-4.
    View PubMed
  22. Cheville AL, Novotny PJ, Sloan JA, Basford JR, Wampfler JA, Garces YI, Jatoi A, Yang P. The value of a symptom cluster of fatigue, dyspnea, and cough in predicting clinical outcomes in lung cancer survivors. J Pain Symptom Manage. 2011 Aug; 42(2):213-21. Epub 2011 Mar 12.
    View PubMed
  23. Cheville AL, Novotny PJ, Sloan JA, Basford JR, Wampfler JA, Garces YI, Jatoi A, Yang P. Fatigue, dyspnea, and cough comprise a persistent symptom cluster up to five years after diagnosis with lung cancer. J Pain Symptom Manage. 2011 Aug; 42(2):202-12. Epub 2011 Mar 12.
    View PubMed
  24. Jatoi A, Breitkopf CR. Is Spanish language a barrier to domestic violence assessment? J Womens Health (Larchmt). 2011 Jul; 20(7):1111-6. Epub 2011 Jun 01.
    View PubMed
  25. Kovtun IV, Harris KJ, Jatoi A, Jevremovic D. Increased incidence of endometrioid tumors caused by aberrations in E-cadherin promoter of mismatch repair-deficient mice. Carcinogenesis. 2011 Jul; 32(7):1085-92. Epub 2011 May 05.
    View PubMed
  26. Mitchell J, Jatoi A. Parenteral nutrition in patients with advanced cancer: merging perspectives from the patient and healthcare provider. Semin Oncol. 2011 Jun; 38(3):439-42.
    View PubMed
  27. Stephens EK, Nguyen PL, Jatoi A. Practical strategies to circumvent and/or surmount six barriers in health disparities research: observations from a pilot project among Vietnamese Americans. J Cancer Educ. 2011 Jun; 26(2):243-7.
    View PubMed
  28. Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, Jatoi A, Loprinzi C, MacDonald N, Mantovani G, Davis M, Muscaritoli M, Ottery F, Radbruch L, Ravasco P, Walsh D, Wilcock A, Kaasa S, Baracos VE. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011 May; 12(5):489-95. Epub 2011 Feb 04.
    View PubMed
  29. Ramiscal JA, Jatoi A. Bevacizumab-induced nasal septal perforation: incidence of symptomatic, confirmed event(s) in colorectal cancer patients. Acta Oncol. 2011 May; 50(4):578-81. Epub 2010 Nov 26.
    View PubMed
  30. Mc Kean H, Stella PJ, Hillman SL, Rowland KM, Cannon MW, Behrens RJ, Gross GG, Sborov MD, Friedman EL, Jatoi A. Exploring therapeutic decisions in elderly patients with non-small cell lung cancer: results and conclusions from North Central Cancer Treatment Group Study N0222. Cancer Invest. 2011 May; 29(4):266-71. Epub 2011 Feb 23.
    View PubMed
  31. Sood R, Shuster L, Smith R, Vincent A, Jatoi A. Counseling postmenopausal women about bioidentical hormones: ten discussion points for practicing physicians. J Am Board Fam Med. 2011 Mar-Apr; 24(2):202-10.
    View PubMed
  32. Solomon BM, Jatoi A. Epidermal growth factor receptor (EGFR) inhibitor-induced rash: a consecutive patient series that illustrates the need for rigorous palliative trials. J Palliat Med. 2011 Feb; 14(2):153-6. Epub 2011 Jan 12.
    View PubMed
  33. Aldairy Y, Nguyen PL, Jatoi A. Bone pain from granulocyte colony stimulating factor: does clinical trial sponsorship by a pharmaceutical company influence its reporting? Eur J Cancer Care (Engl). 2011 Jan; 20(1):72-6.
    View PubMed
  34. Butts M, Jatoi A. A systematic compilation of reports published on opioid-related problems. J Opioid Manag. 2011 Jan-Feb; 7(1):35-45.
    View PubMed
  35. Vincent A, Whipple MO, Luedtke CA, Oh TH, Sood R, Smith RL, Jatoi A. Pain and other symptom severity in women with fibromyalgia and a previous hysterectomy. J Pain Res. 2011; 4:325-9. Epub 2011 Oct 07.
    View PubMed
  36. Mateen FJ, Nassar A, Bardia A, Jatoi A, Haddock MG, Buckner JC, Lachance DH. Spinal intradural extraosseous Ewing's sarcoma. Rare Tumors. 2011; 3(1):e7. Epub 2011 Mar 30.
    View PubMed
  37. Dodson S, Baracos VE, Jatoi A, Evans WJ, Cella D, Dalton JT, Steiner MS. Muscle wasting in cancer cachexia: clinical implications, diagnosis, and emerging treatment strategies. Annu Rev Med. 2011; 62:265-79.
    View PubMed
  38. Vaidya R, Sood R, Karlin N, Jatoi A. Benzodiazepine use in breast cancer survivors: findings from a consecutive series of 1,000 patients. Oncology. 2011; 81(1):9-11. Epub 2011 Sep 02.
    View PubMed
  39. Tan TS, Jatoi A. End-of-life hospital costs in cancer patients: do advance directives or routes of hospital admission make a difference? Oncology. 2011; 80(1-2):118-22. Epub 2011 Jun 14.
    View PubMed
  40. Sood R, Jatoi A. Integrative nutritional approaches to loss of weight and appetite in patients with advanced cancer. European Journal of Integrative Medicine. 2011; 3(3):e233-6.
  41. Jatoi A. Integrative and complementary medicine among cancer patients: At what price? European Journal of Integrative Medicine. 2011; 3(3):e139-41.
  42. Jatoi A, Soori G, Foster NR, Hiatt BK, Knost JA, Fitch TR, Callister MD, Nichols FC 3rd, Husted TM, Alberts SR. Phase II study of preoperative pemetrexed, carboplatin, and radiation followed by surgery for locally advanced esophageal cancer and gastroesophageal junction tumors. J Thorac Oncol. 2010 Dec; 5(12):1994-8.
    View PubMed
  43. Burnette B, Jatoi A. Parenteral nutrition in patients with cancer: recent guidelines and a need for further study. Curr Opin Support Palliat Care. 2010 Dec; 4(4):272-5.
    View PubMed
  44. Miller RC, Atherton PJ, Kabat BF, Fredericksen MB, Geno DM, Deschamps C, Jatoi A, Sloan JA, Romero Y. Marital status and quality of life in patients with esophageal cancer or Barrett's esophagus: the mayo clinic esophageal adenocarcinoma and Barrett's esophagus registry study. Dig Dis Sci. 2010 Oct; 55(10):2860-8. Epub 2010 Jan 22.
    View PubMed
  45. Jatoi A, Schild SE, Foster N, Henning GT, Dornfeld KJ, Flynn PJ, Fitch TR, Dakhil SR, Rowland KM, Stella PJ, Soori GS, Adjei AA. A phase II study of cetuximab and radiation in elderly and/or poor performance status patients with locally advanced non-small-cell lung cancer (N0422). Ann Oncol. 2010 Oct; 21(10):2040-4. Epub 2010 Jun 21.
    View PubMed
  46. Jatoi A, Qi Y, Kendall G, Jiang R, McNallan S, Cunningham J, Mandrekar S, Yang P. The cancer anorexia/weight loss syndrome: exploring associations with single nucleotide polymorphisms (SNPs) of inflammatory cytokines in patients with non-small cell lung cancer. Support Care Cancer. 2010 Oct; 18(10):1299-304. Epub 2009 Dec 15.
    View PubMed
  47. Larson BR, Looker S, Herrera DM, Creagan ET, Hayman SR, Kaur JS, Jatoi A. Cancer patients and their companion animals: results from a 309-patient survey on pet-related concerns and anxieties during chemotherapy. J Cancer Educ. 2010 Sep; 25(3):396-400. Epub 2010 Feb 24.
    View PubMed
  48. Behl D, Jatoi A. What do oncologists say about chemotherapy at the very end of life? Results from a semiqualitative survey. J Palliat Med. 2010 Jul; 13(7):831-5.
    View PubMed
  49. Jatoi A, Smith EL, Gunderson HD, Hartgers ML, Looker SA, Santana-Davila R, McWilliams RR. Capecitabine and temozolomide: design, implementation, and preliminary outcomes from a pilot project to ensure safe prescribing of oral chemotherapy. J Oncol Pract. 2010 Jul; 6(4):210-2. Epub 2010 Jun 22.
    View PubMed
  50. Halfdanarson TR, Jatoi A. Oral cancer chemotherapy: the critical interplay between patient education and patient safety. Curr Oncol Rep. 2010 Jul; 12(4):247-52.
    View PubMed
  51. Jatoi A. Cancer chemotherapy: with or without food? Support Care Cancer. 2010 May; 18 Suppl 2:S13-6. Epub 2009 Jun 01.
    View PubMed
  52. Jatoi A, Ritter HL, Dueck A, Nguyen PL, Nikcevich DA, Luyun RF, Mattar BI, Loprinzi CL. A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and/or poor performance non-small cell lung cancer patients (N01C9). Lung Cancer. 2010 May; 68(2):234-9. Epub 2009 Aug 08.
    View PubMed
  53. Jatoi A, Foster NR, Egner JR, Burch PA, Stella PJ, Rubin J, Dakhil SR, Sargent DJ, Murphy BR, Alberts SR. Older versus younger patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction, and stomach: a pooled analysis of eight consecutive North Central Cancer Treatment Group (NCCTG) trials. Int J Oncol. 2010 Mar; 36(3):601-6.
    View PubMed
  54. Hartgers M, Jatoi A. E-mail and photographs: a case report of a patient-initiated diagnostic tool in the era of electronic communication. J Palliat Med. 2010 Mar; 13(3):335-7.
    View PubMed
  55. Chen J, Jiang R, Garces YI, Jatoi A, Stoddard SM, Sun Z, Marks RS, Liu Y, Yang P. Prognostic factors for limited-stage small cell lung cancer: a study of 284 patients. Lung Cancer. 2010 Feb; 67(2):221-6. Epub 2009 Jun 03.
    View PubMed
  56. Wood LS, Lemont H, Jatoi A, Lacouture ME, Robert C, Keating K, Anderson R. Practical considerations in the management of hand-foot skin reaction caused by multikinase inhibitors. Community Oncol. 2010; 7(1):23-9.
  57. Jatoi A, Thrower A, Sloan JA, Flynn PJ, Wentworth-Hartung NL, Dakhil SR, Mattar BI, Nikcevich DA, Novotny P, Sekulic A, Loprinzi CL. Does sunscreen prevent epidermal growth factor receptor (EGFR) inhibitor-induced rash? Results of a placebo-controlled trial from the North Central Cancer Treatment Group (N05C4). Oncologist. 2010; 15(9):1016-22. Epub 2010 Aug 26.
    View PubMed
  58. Jatoi A. Bisphosphonates: preventing skeletal morbidity and maybe doing more. Curr Oncol Rep. 2009 Jul; 11(4):251-2.
    View PubMed
  59. Anderson R, Jatoi A, Robert C, Wood LS, Keating KN, Lacouture ME. Search for evidence-based approaches for the prevention and palliation of hand-foot skin reaction (HFSR) caused by the multikinase inhibitors (MKIs). Oncologist. 2009 Mar; 14(3):291-302. Epub 2009 Mar 10.
    View PubMed
  60. Huang J, Jatoi A. Morbidity and mortality in patients with cancer who become nonambulatory after spinal cord compression: a case series on end-of-life care. J Palliat Med. 2009 Mar; 12(3):219-22.
    View PubMed
  61. Jatoi A. In search of rigorous data on how to palliate the EGFR inhibitor-induced rash. Oncology (Williston Park) 2009 Feb; 23(2):196, 198.
    View PubMed
  62. Donahue JM, Nichols FC, Li Z, Schomas DA, Allen MS, Cassivi SD, Jatoi A, Miller RC, Wigle DA, Shen KR, Deschamps C. Complete pathologic response after neoadjuvant chemoradiotherapy for esophageal cancer is associated with enhanced survival. Ann Thorac Surg. 2009 Feb; 87(2):392-8; discussion 398-9.
    View PubMed
  63. Jatoi A, Green EM, Rowland KM Jr, Sargent DJ, Alberts SR. Clinical predictors of severe cetuximab-induced rash: observations from 933 patients enrolled in north central cancer treatment group study N0147. Oncology. 2009; 77(2):120-3. Epub 2009 Jul 22.
    View PubMed
  64. Jacobs NL, Que FG, Miller RC, Vege SS, Farnell MB, Jatoi A. Cumulative morbidity and late mortality in long-term survivors of exocrine pancreas cancer. J Gastrointest Cancer. 2009; 40(1-2):46-50.
    View PubMed
  65. Tan TS, Walia T, Galanis E, Goetz MP, Rubin J, Jatoi A. If you hold it off-hours, will they come? Results from a feasibility project intended to stimulate interest in the physician-investigator career path among medical oncology trainees. J Cancer Educ. 2009; 24(3):200-3.
    View PubMed
  66. Jatoi A, Hillman SL, Ziegler KL, Stella PJ, Soori GS, Rowland KM. Is social support associated with improved clinical outcomes in geriatric lung cancer patients? Observations from North Central Cancer Treatment Group Studies N9921 and N0222. Cancer Manag Res. 2009; 1:61-8. Epub 2009 Jun 17.
    View PubMed
  67. Evans WJ, Morley JE, Argiles J, Bales C, Baracos V, Guttridge D, Jatoi A, Kalantar-Zadeh K, Lochs H, Mantovani G, Marks D, Mitch WE, Muscaritoli M, Najand A, Ponikowski P, Rossi Fanelli F, Schambelan M, Schols A, Schuster M, Thomas D, Wolfe R, Anker SD. Cachexia: a new definition. Clin Nutr. 2008 Dec; 27(6):793-9. Epub 2008 Aug 21.
    View PubMed
  68. Walia T, Quevedo JF, Hobday TJ, Croghan G, Jatoi A. Colorectal cancer patients with liver metastases and severe hyperbilirubinemia: A consecutive series that explores the benefits and risks of chemotherapy. Ther Clin Risk Manag. 2008 Dec; 4(6):1363-6.
    View PubMed
  69. Jatoi A, Nguyen PL. Side effects and pharmaceutical company bias: adverse event reporting in cancer supportive and palliative care trials. Expert Opin Investig Drugs. 2008 Dec; 17(12):1787-90.
    View PubMed
  70. Jatoi A, Nguyen PL. Do patients die from rashes from epidermal growth factor receptor inhibitors? A systematic review to help counsel patients about holding therapy. Oncologist. 2008 Nov; 13(11):1201-4. Epub 2008 Nov 06.
    View PubMed
  71. Jatoi A, Rowland K, Sloan JA, Gross HM, Fishkin PA, Kahanic SP, Novotny PJ, Schaefer PL, Johnson DB, Tschetter LK, Loprinzi CL. Tetracycline to prevent epidermal growth factor receptor inhibitor-induced skin rashes: results of a placebo-controlled trial from the North Central Cancer Treatment Group (N03CB). Cancer. 2008 Aug 15; 113(4):847-53.
    View PubMed
  72. Corsini MM, Miller RC, Haddock MG, Donohue JH, Farnell MB, Nagorney DM, Jatoi A, McWilliams RR, Kim GP, Bhatia S, Iott MJ, Gunderson LL. Adjuvant radiotherapy and chemotherapy for pancreatic carcinoma: the Mayo Clinic experience (1975-2005). J Clin Oncol. 2008 Jul 20; 26(21):3511-6.
    View PubMed
  73. Clark MM, Novotny PJ, Patten CA, Rausch SM, Garces YI, Jatoi A, Sloan JA, Yang P. Motivational readiness for physical activity and quality of life in long-term lung cancer survivors. Lung Cancer. 2008 Jul; 61(1):117-22. Epub 2008 Feb 19.
    View PubMed
  74. Mateen FJ, Jatoi A, Lineberry TW, Aranguren D, Creagan ET, Croghan GA, Jett JR, Marks RS, Molina JR, Richardson RL. Do patients with schizophrenia receive state-of-the-art lung cancer therapy? A brief report. Psychooncology. 2008 Jul; 17(7):721-5.
    View PubMed
  75. Solomon BM, Jatoi A. Rash from EGFR inhibitors: opportunities and challenges for palliation. Curr Oncol Rep. 2008 Jul; 10(4):304-8.
    View PubMed
  76. Galanis E, Carlson SK, Foster NR, Lowe V, Quevedo F, McWilliams RR, Grothey A, Jatoi A, Alberts SR, Rubin J. Phase I trial of a pathotropic retroviral vector expressing a cytocidal cyclin G1 construct (Rexin-G) in patients with advanced pancreatic cancer. Mol Ther. 2008 May; 16(5):979-84. Epub 2008 Mar 18.
    View PubMed
  77. McKean H, Looker S, Hartmann LC, Hayman SR, Kaur JS, McWilliams RR, Peethambaram PP, Stahl JF, Jatoi A. Are cancer survivors/patients knowledgeable about osteoporosis? Results from a survey of 285 chemotherapy-treated cancer patients and their companions. J Nutr Educ Behav. 2008 May-Jun; 40(3):144-8.
    View PubMed
  78. Jatoi A, Dakhil SR, Foster NR, Ma C, Rowland KM Jr, Moore DF Jr, Jaslowski AJ, Thomas SP, Hauge MD, Flynn PJ, Stella PJ, Alberts SR. Bortezomib, paclitaxel, and carboplatin as a first-line regimen for patients with metastatic esophageal, gastric, and gastroesophageal cancer: phase II results from the North Central Cancer Treatment Group (N044B). J Thorac Oncol. 2008 May; 3(5):516-20.
    View PubMed
  79. Halfdanarson TR, Thordardottir E, West CP, Jatoi A. Does dietary counseling improve quality of life in cancer patients? A systematic review and meta-analysis. J Support Oncol. 2008 May-Jun; 6(5):234-7.
    View PubMed
  80. Jatoi A. Weight loss in patients with advanced cancer: effects, causes, and potential management. Curr Opin Support Palliat Care. 2008 Mar; 2(1):45-8.
    View PubMed
  81. Kovtun IV, Engh J, Jatoi A. A survey of patient advocates within the National Cancer Institute's Prostate Cancer SPORE Program: who are they? what motivates them? what might they tell us? J Cancer Educ. 2008; 23(4):222-5.
    View PubMed
  82. Singh PP, Jatoi A. Do gender-based disparities in authorship also exist in cancer palliative care? A 15-year survey of the cancer palliative care literature. J Cancer Educ. 2008; 23(3):192-4.
    View PubMed
  83. Tan TS, Jatoi A. An update on advance directives in the medical record: findings from 1186 consecutive patients with unresectable exocrine pancreas cancer. J Gastrointest Cancer. 2008; 39(1-4):100-3. Epub 2009 Jan 06.
    View PubMed
  84. Katipamula R, Jatoi A, Foster NR, Nichols F, Rubin J, Callister M, Gunderson L, Alberts S. Pemetrexed, Carboplatin, and Concomitant Radiation followed by Surgery for Locally Advanced Esophageal Cancer: Results of a Planned Interim Toxicity Analysis of North Central Cancer Treatment Group Study N044E. Clin Med Oncol. 2008; 2:223-5. Epub 2008 Apr 01.
    View PubMed
  85. Jatoi A, Novotny P, Cassivi S, Clark MM, Midthun D, Patten CA, Sloan J, Yang P. Does marital status impact survival and quality of life in patients with non-small cell lung cancer? Observations from the mayo clinic lung cancer cohort. Oncologist. 2007 Dec; 12(12):1456-63.
    View PubMed
  86. Jatoi A, Martenson JA, Foster NR, McLeod HL, Lair BS, Nichols F, Tschetter LK, Moore DF Jr, Fitch TR, Alberts SR, North Central Cancer Treatment Group (N0044). Paclitaxel, carboplatin, 5-fluorouracil, and radiation for locally advanced esophageal cancer: phase II results of preliminary pharmacologic and molecular efforts to mitigate toxicity and predict outcomes: North Central Cancer Treatment Group (N0044). Am J Clin Oncol. 2007 Oct; 30(5):507-13.
    View PubMed
  87. Jatoi A, Dakhil SR, Nguyen PL, Sloan JA, Kugler JW, Rowland KM Jr, Soori GS, Wender DB, Fitch TR, Novotny PJ, Loprinzi CL. A placebo-controlled double blind trial of etanercept for the cancer anorexia/weight loss syndrome: results from N00C1 from the North Central Cancer Treatment Group. Cancer. 2007 Sep 15; 110(6):1396-403.
    View PubMed
  88. Alsawaf MA, Jatoi A. Shopping for nutrition-based complementary and alternative medicine on the Internet: how much money might cancer patients be spending online? J Cancer Educ. 2007 Fall; 22(3):174-6.
    View PubMed
  89. Schild SE, Mandrekar SJ, Jatoi A, McGinnis WL, Stella PJ, Deming RL, Jett JR, Garces YI, Allen KL, Adjei AA, North Central Cancer Treatment GroupThis study was conducted as a collaborative trial of the North Central Cancer Treatment Group and the Mayo The value of combined-modality therapy in elderly patients with stage III nonsmall cell lung cancer. Cancer. 2007 Jul 15; 110(2):363-8.
    View PubMed
  90. Behl D, Jatoi A. Pharmacological options for advanced cancer patients with loss of appetite and weight. Expert Opin Pharmacother. 2007 Jun; 8(8):1085-90.
    View PubMed
  91. Aletti GD, Gallenberg MM, Cliby WA, Jatoi A, Hartmann LC. Current management strategies for ovarian cancer. Mayo Clin Proc. 2007 Jun; 82(6):751-70.
    View PubMed
  92. Ma C, Jatoi A. Wine for appetite loss: "how do you know?". J Clin Oncol. 2007 Apr 1; 25(10):1285-7.
    View PubMed
  93. Halyard MY, Jatoi A, Sloan JA, Bearden JD 3rd, Vora SA, Atherton PJ, Perez EA, Soori G, Zalduendo AC, Zhu A, Stella PJ, Loprinzi CL. Does zinc sulfate prevent therapy-induced taste alterations in head and neck cancer patients? Results of phase III double-blind, placebo-controlled trial from the North Central Cancer Treatment Group (N01C4). Int J Radiat Oncol Biol Phys. 2007 Apr 1; 67(5):1318-22.
    View PubMed
  94. Loprinzi CL, Barton DL, Jatoi A, Sloan J, Martenson J, Steensma D, Rao R, Novotny P, Sood A, Grothey A, Minasian L, Windschitl H. Symptom control trials: a 20-year experience. J Support Oncol. 2007 Mar; 5(3):119-25, 128.
    View PubMed
  95. Ma C, Mandrekar SJ, Alberts SR, Croghan GA, Jatoi A, Reid JM, Hanson LJ, Bruzek L, Tan AD, Pitot HC, Erlichman C, Wright JJ, Adjei AA. A phase I and pharmacologic study of sequences of the proteasome inhibitor, bortezomib (PS-341, Velcade), in combination with paclitaxel and carboplatin in patients with advanced malignancies. Cancer Chemother Pharmacol. 2007 Feb; 59(2):207-15. Epub 2006 Jun 09.
    View PubMed
  96. Jatoi A, Burch P, Hillman D, Vanyo JM, Dakhil S, Nikcevich D, Rowland K, Morton R, Flynn PJ, Young C, Tan W, North Central Cancer Treatment Group. A tomato-based, lycopene-containing intervention for androgen-independent prostate cancer: results of a Phase II study from the North Central Cancer Treatment Group. Urology. 2007 Feb; 69(2):289-94.
    View PubMed
  97. Halfdanarson TR, Jatoi A. Chocolate as a cough suppressant: rationale and justification for an upcoming clinical trial. Support Cancer Ther. 2007 Jan 1; 4(2):119-22.
    View PubMed
  98. Jatoi A, Aranguren D. A critical look at the role of chemotherapy in older patients with non-small cell lung cancer. J Thorac Oncol. 2007 Jan; 2(1):83-90.
    View PubMed
  99. Jatoi A, Nguyen PL, Foster N, Sun D, Stella PJ, Campbell M, Tschetter LK, Dakhil SR, Mailliard JA, Nikcevich DA. Interleukin-1 genetic polymorphisms and their relationship to the cancer anorexia/weight loss syndrome in metastatic gastric and gastroesophageal junction adenocarcinoma. J Support Oncol. 2007 Jan; 5(1):41-6.
    View PubMed
  100. McKean H, Miller RC, Jatoi A. Non-traumatic vertebral fractures in patients with locally advanced esophageal cancer: a previously unreported, unrecognized problem. Dis Esophagus. 2007; 20(2):102-6.
    View PubMed
  101. Jatoi A. Sunshine and rash: Testing the role of sunscreen to prevent epidermal growth factor receptor inhibitor-induced rash. Supportive Cancer Ther. 2007; 4(4):198-202.
  102. Jatoi A. Pharmacologic therapy for the cancer anorexia/weight loss syndrome: A data-driven, practical approach. J Support Oncol. 2006 Nov-Dec; 4(10):499-502.
    View PubMed
  103. Jatoi A, Burch P, Hillman D, Vanyo J, Dakhil S, Nikcevich D, Rowland K, Morton R, Flynn P, Young C, Tan W. A tomato-based, lycopene-containing intervention for androgen-independent prostate cancer: results of a phase II study from the North Central Cancer Treatment Group. J Urol. 2006 Oct 19; 69(2):289-294.
  104. Jatoi A, Jacobs JA, Zimmermann E, Johnson ME, Nguyen PL, Hartmann LC. Helping people cope with bereavement: an opportunity for health care providers to link Web-based resources across Minnesota. Minn Med. 2006 Oct; 89(10):42-4.
    View PubMed
  105. Mateen F, Jatoi A. Megestrol acetate for the palliation of anorexia in advanced, incurable cancer patients. Clin Nutr. 2006 Oct; 25(5):711-5. Epub 2006 Jul 25.
    View PubMed
  106. Barton DL, Loprinzi C, Jatoi A, Vincent A, Limburg P, Bauer B, Sood A, Good M, Bearden JD 4th, Kelaghan J, Sloan J. Can complementary and alternative medicine clinical cancer research be successfully accomplished? The Mayo Clinic-North Central Cancer Treatment Group experience. J Soc Integr Oncol. 2006 Fall; 4(4):143-52.
    View PubMed
  107. Patiyil S, Chan SN, Jatoi A. New agents, new rashes: an update on skin complications from cancer chemotherapy. Curr Oncol Rep. 2006 Jul; 8(4):269-74.
    View PubMed
  108. Chan SN, Okuno SH, Jatoi A. Causes and outcomes of spontaneous pneumothoraces in solid tumor cancer patients: an update for the medical oncologist. J Thorac Oncol. 2006 May; 1(4):335-8.
    View PubMed
  109. Giordano KF, Jatoi A, Stella PJ, Foster N, Tschetter LK, Alberts SR, Dakhil SR, Mailliard JA, Flynn PJ, Nikcevich DA, North Central Cancer Treatment Group. Docetaxel and capecitabine in patients with metastatic adenocarcinoma of the stomach and gastroesophageal junction: a phase II study from the North Central Cancer Treatment Group. Ann Oncol. 2006 Apr; 17(4):652-6. Epub 2006 Feb 23.
    View PubMed
  110. Jatoi A, Murphy BR, Foster NR, Nikcevich DA, Alberts SR, Knost JA, Fitch TR, Rowland KM Jr, North Central Cancer Treatment Group. Oxaliplatin and capecitabine in patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction and gastric cardia: a phase II study from the North Central Cancer Treatment Group. Ann Oncol. 2006 Jan; 17(1):29-34. Epub 2005 Nov 22.
    View PubMed
  111. McKian KP, Miller RC, Cassivi SD, Jatoi A. Curing patients with locally advanced esophageal cancer: an update on multimodality therapy. Dis Esophagus. 2006; 19(6):448-53.
    View PubMed
  112. Jatoi A, Foster N, Wieland B, Murphy B, Nikcevich D, LaPlant B, Palcic MM, Baracos V. The proteolysis-inducing factor: in search of its clinical relevance in patients with metastatic gastric/esophageal cancer. Dis Esophagus. 2006; 19(4):241-7.
    View PubMed
  113. Jatoi A, Hillman S, Stella P, Green E, Adjei A, Nair S, Perez E, Amin B, Schild SE, Castillo R, Jett JR, North Central Cancer Treatment Group. Should elderly non-small-cell lung cancer patients be offered elderly-specific trials? Results of a pooled analysis from the North Central Cancer Treatment Group. J Clin Oncol. 2005 Dec 20; 23(36):9113-9.
    View PubMed
  114. Jatoi A, Giordano KF, Nguyen PL, Sloan J, Hartmann LC. Targeting and palliating malignant ascites: an overview of an upcoming clinical trial from the north central cancer treatment group. Support Cancer Ther. 2005 Oct 1; 3(1):59-62.
    View PubMed
  115. Giordano KF, Jatoi A, Adjei AA, Creagan ET, Croghan G, Frytak S, Jett JR, Marks R, Molina J, Okuno S, Richardson RL. Ramifications of severe organ dysfunction in newly diagnosed patients with small cell lung cancer: contemporary experience from a single institution. Lung Cancer. 2005 Aug; 49(2):209-15.
    View PubMed
  116. Jatoi A. Omega-3 fatty acid supplements for cancer-associated weight loss. Nutr Clin Pract. 2005 Aug; 20(4):394-9.
    View PubMed
  117. Giordano KF, Jatoi A. The cancer anorexia/weight loss syndrome: therapeutic challenges. Curr Oncol Rep. 2005 Jul; 7(4):271-6.
    View PubMed
  118. Jatoi A. Fish oil, lean tissue, and cancer: is there a role for eicosapentaenoic acid in treating the cancer anorexia/weight loss syndrome? Crit Rev Oncol Hematol. 2005 Jul; 55(1):37-43.
    View PubMed
  119. Jatoi A, Williams B, Nichols F, Marks R, Aubry MC, Wampfler J, Finke EE, Yang P. Is voluntary vitamin and mineral supplementation associated with better outcome in non-small cell lung cancer patients? Results from the Mayo Clinic lung cancer cohort. Lung Cancer. 2005 Jul; 49(1):77-84.
    View PubMed
  120. Schild SE, Stella PJ, Brooks BJ, Mandrekar S, Bonner JA, McGinnis WL, Mailliard JA, Krook JE, Deming RL, Adjei AA, Jatoi A, Jett JR. Results of combined-modality therapy for limited-stage small cell lung carcinoma in the elderly. Cancer. 2005 Jun 1; 103(11):2349-54.
    View PubMed
  121. Jatoi A, Alberts SR, Foster N, Morton R, Burch P, Block M, Nguyen PL, Kugler J, North Central Cancer Treatment Group. Is bortezomib, a proteasome inhibitor, effective in treating cancer-associated weight loss? Preliminary results from the North Central Cancer Treatment Group. Support Care Cancer. 2005 Jun; 13(6):381-6. Epub 2005 Mar 10
    View PubMed
  122. Joque L, Jatoi A. Total parenteral nutrition in cancer patients: why and when? Nutrition in Clinical Care. 2005 Apr-Jun; 8(2):89-92.
    View PubMed
  123. Hoda D, Jatoi A, Burnes J, Loprinzi C, Kelly D. Should patients with advanced, incurable cancers ever be sent home with total parenteral nutrition? A single institution's is 20-year experience. Cancer. 2005 Feb 15; 103(4):863-8.
    View PubMed
  124. Jatoi A, Kahanic SP, Frytak S, Schaefer P, Foote RL, Sloan J, Petersen RC. Donepezil and vitamin E for preventing cognitive dysfunction in small cell lung cancer patients: preliminary results and suggestions for future study designs. Support Care Cancer. 2005 Jan; 13(1):66-9. Epub 2004 Oct 09.
    View PubMed
  125. Jatoi A, Williams BA, Marks R, Nichols FC, Aubry MC, Wampfler J, Yang P. Exploring vitamin and mineral supplementation and purported clinical effects in patients with small cell lung cancer: Results from the Mayo Clinic Lung Cancer Cohort. Nutr Cancer. 2005; 51(1):7-12.
    View PubMed
  126. Jatoi A, Jett JR, Sloan J, Novotny P, Ford J, Prabhakar U, Loprinzi CL. A pilot study on safety and pharmacokinetics of infliximab for the cancer anorexia/weight loss syndrome in non-small-cell lung cancer patients. Support Care Cancer. 2004 Dec; 12(12):859-63. Epub 2004 Sep 15.
    View PubMed
  127. Jatoi A, Martenson J, Mahoney MR, Lair BS, Brindle JS, Nichols F, Caron N, Rowland K, Tschetter L, Alberts S. Results of a planned interim toxicity analysis with trimodality therapy, including carboplatin AUC = 4, paclitaxel, 5-fluorouracil, amifostine, and radiation for locally advanced esophageal cancer: preliminary analyses and treatment recommendations from the North Central Cancer Treatment Group. Int Semin Surg Oncol. 2004 Nov 08; 1(1):9.
    View PubMed
  128. Jatoi A, Egner J, Loprinzi CL, Sloan JA, Novotny PJ, Dakhil SR, Mailliard JA, Klee GG, Krook JE. Investigating the utility of serum cytokine measurements in a multi-institutional cancer anorexia/weight loss trial. Support Care Cancer. 2004 Sep; 12(9):640-4.
    View PubMed
  129. Jatoi A, Sideras K, Nguyen PL. Tumor Necrosis Factor-alpha as a Treatment Target for the Cancer Anorexia/Weight Loss Syndrome. Support Cancer Ther. 2004 Jul 1; 1(4):237-42.
    View PubMed
  130. Jatoi A, Rowland K, Loprinzi CL, Sloan JA, Dakhil SR, MacDonald N, Gagnon B, Novotny PJ, Mailliard JA, Bushey TI, Nair S, Christensen B, North Central Cancer Treatment Group. An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort. J Clin Oncol. 2004 Jun 15; 22(12):2469-76.
    View PubMed
  131. Young CYF, Jatoi A, Ward JF, Blute ML. The effects of dietary factors on the androgen receptor and related cellular factors in prostate cancer. Curr Med Chem. 2004 Apr; 11(7):909-23.
    View PubMed
  132. Kanard A, Jatoi A, Castillo R, Geyer S, Schulz TK, Fitch TR, Rowland KM, Nair S, Krook JE, Kugler JW. Oral vinorelbine for the treatment of metastatic non-small cell lung cancer in elderly patients: a phase II trial of efficacy and toxicity. Lung Cancer. 2004 Mar; 43(3):345-53.
    View PubMed
  133. Kanard A, Frytak S, Jatoi A. Cognitive dysfunction in patients with small-cell lung cancer: incidence, causes, and suggestions on management. J Support Oncol. 2004 Mar-Apr; 2(2):127-32; discussion 133-5, 138-40.
    View PubMed
  134. de Andrade M, Ebbert JO, Wampfler JA, Miller DL, Marks RS, Croghan GA, Jatoi A, Finke EE, Sellers TA, Yang P. Environmental tobacco smoke exposure in women with lung cancer. Lung Cancer. 2004 Feb; 43(2):127-34.
    View PubMed
  135. Jatoi A, Nguyen PL. Weight loss in lung cancer patients with refractory, metastatic disease: clinical implications and therapeutic strategies. Oncology Nutrition Connection. 2004 Spr; 12(2):1, 3-5.
  136. Jatoi A, Podratz KC, Gill P, Hartmann LC. Pathophysiology and palliation of inoperable bowel obstruction in patients with ovarian cancer. J Support Oncol. 2004; 2(4):323-34.
    View PubMed
  137. Jatoi A, Foster N, Johnson P, Klee G, Quevedo JF, Morton RF, Nair S, Kardinal CG, Mailliard JA. Investigating four 'myths' surrounding dysphagia in patients with metastatic esophageal cancer. A multi-institutional study from the North Central Cancer Treatment Group. Dis Esophagus. 2004; 17(4):292-6.
    View PubMed
  138. Jatoi A, Ellison N, Burch PA, Quesenberry J, Shogren K, Sloan JA, Young CYF. Prostate cancer patients with maspin-negative tumors can live over a decade. Cancer Therapy. 2004; 2:173-6.
  139. Jatoi A. Aggressive multimodality therapy for patients with locally advanced esophageal cancer: is there a role for amifostine? Semin Oncol. 2003 Dec; 30(6 Suppl 18):72-5.
    View PubMed
  140. Jacobson SD, Loprinzi CL, Sloan JA, Wilke JL, Novotny PJ, Okuno SH, Jatoi A, Moynihan TJ. Glutamine does not prevent paclitaxel-associated myalgias and arthralgias. J Support Oncol2003 Nov-Dec; 1(4):274-8.
    View PubMed
  141. Jatoi A, Stella PJ, Hillman S, Mailliard JA, Vanone S, Perez EA, Cannon MW, Geyer S, Wiesenfeld M, Jett JR. Weekly carboplatin and paclitaxel in elderly non-small-cell lung cancer patients (>or=65 years of age): a phase II North Central Cancer Treatment Group study. Am J Clin Oncol. 2003 Oct; 26(5):441-7.
    View PubMed
  142. Schild SE, Stella PJ, Geyer SM, Bonner JA, McGinnis WL, Mailliard JA, Brindle J, Jatoi A, Jett JR, North Central Cancer Treatment Group. The outcome of combined-modality therapy for stage III non-small-cell lung cancer in the elderly. J Clin Oncol. 2003 Sep 1; 21(17):3201-6. Epub 2003 Jul 21.
    View PubMed
  143. Jatoi A, Suman VJ, Schaefer P, Block M, Loprinzi C, Roche P, Garneau S, Morton R, Stella PJ, Alberts SR, Pittelkow M, Sloan J, Pagano R. A phase II study of topical ceramides for cutaneous breast cancer. Breast Cancer Res Treat. 2003 Jul; 80(1):99-104.
    View PubMed
  144. Jatoi A, Hillman S, Stella PJ, Mailliard JA, Sloan J, Vanone S, Cannon MW, Kutteh L, Kanard A, Jett JR. Daily activities: exploring their spectrum and prognostic impact in older, chemotherapy-treated lung cancer patients. Support Care Cancer. 2003 Jul; 11(7):460-4.
    View PubMed
  145. Jatoi A, Kumar S, Sloan JA, Nguyen PL. On appetite and its loss. J Clin Oncol. 2003 May 1; 21(9 Suppl):79s-81s.
    View PubMed
  146. Jatoi A, Ellison N, Burch PA, Sloan JA, Dakhil SR, Novotny P, Tan W, Fitch TR, Rowland KM, Young CY, Flynn PJ. A phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma. Cancer. 2003 Mar 15; 97(6):1442-6.
    View PubMed
  147. Jatoi A. Why should we care about the cancer anorexia/weight loss syndrome? Oncology (Huntington) 2003 Feb; 17(2 Suppl 2):5-6.
    View PubMed
  148. Jatoi A, Loprinzi CL. The cancer anorexia/weight loss syndrome-a review of therapeutic strategies. Business Briefing:European PharmacoTherapy. 2003;102-4.
  149. Somerfield M, Jatoi A, Nguyen PL, Kumar S, Sloan J, Loprinzi CL. Hazards of quality-of-life data for clinical decision making. J Clin Oncol. 2003; 21(9 suppl):82-3.
    View PubMed
  150. Jatoi A, Windschitl HE, Loprinzi CL, Sloan JA, Dakhil SR, Mailliard JA, Pundaleeka S, Kardinal CG, Fitch TR, Krook JE, Novotny PJ, Christensen B. Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study. J Clin Oncol. 2002 Jan 15; 20(2):567-73.
    View PubMed
  151. Jatoi A, Yamashita J, Sloan JA, Novotny PJ, Windschitl HE, Loprinzi CL. Does megestrol acetate down-regulate interleukin-6 in patients with cancer-associated anorexia and weight loss? A North Central Cancer Treatment Group investigation. Support Care Cancer. 2002 Jan; 10(1):71-5.
    View PubMed
  152. Jatoi A, Thomas CR Jr. Esophageal cancer and the esophagus: challenges and potential strategies for selective cytoprotection of the tumor-bearing organ during cancer treatment. Semin Radiat Oncol. 2002 Jan; 12(1 Suppl 1):62-7.
    View PubMed
  153. Jatoi A, Nguyen PL. Anorexia: Treatment options for patients with advanced cancer. Am J Cancer. 2002; 1(4):269-75.
  154. Jatoi A, Tirona MT, Cha SS, Alberts SR, Rowland KM, Morton RF, Nair S, Kardinal CG, Stella PJ, Mailliard JA, Sargen D, Goldberg RM. A phase II trial of docetaxel and CPT-11 in patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction, and gastric cardia. Int J Gastrointest Cancer. 2002; 32(2-3):115-23.
    View PubMed
  155. Jatoi A, Loprinzi CL, Sloan JA, Klee GG, Windschitl HE. Neuropeptide Y, leptin, and cholecystokinin 8 in patients with advanced cancer and anorexia: a North Central Cancer Treatment Group exploratory investigation. Cancer. 2001 Aug 1; 92(3):629-33.
    View PubMed
  156. Jatoi A, Daly BD, Hughes VA, Dallal GE, Kehayias J, Roubenoff R. Do patients with nonmetastatic non-small cell lung cancer demonstrate altered resting energy expenditure? Ann Thorac Surg. 2001 Aug; 72(2):348-51.
    View PubMed
  157. Jatoi A, Daly BD, Kramer G, Mason JB. Folate status among patients with non-small cell lung cancer: a case-control study. J Surg Oncol. 2001 Aug; 77(4):247-52.
    View PubMed
  158. Jatoi A, Cleary MP, Tee CM, Nguyen PL. Weight gain does not preclude increased ubiquitin conjugation in skeletal muscle: an exploratory study in tumor-bearing mice. Ann Nutr Metab. 2001 May-Jun; 45(3):116-120.
    View PubMed
  159. Jatoi A, Loprinzi CL. An update: cancer-associated anorexia as a treatment target. Curr Opin Clin Nutr Metab Care. 2001 May; 4(3):179-82.
    View PubMed
  160. Jatoi A Jr, Loprinzi CL. Current management of cancer-associated anorexia and weight loss. Oncology (Williston Park) 2001 Apr; 15(4):497-502, 508; discussion 508-10.
    View PubMed
  161. Jatoi A, Kumar S, Sloan JA, Nguyen PL. On appetite and its loss. J Clin Oncol. 2000 Aug; 18(15):2930-2.
    View PubMed
  162. Clark JL, Nguyen PL, Jaszcz WB, Jatoi A, Niehans GA. Prognostic variables in male breast cancer. Am Surg. 2000 May; 66(5):502-11.
    View PubMed
  163. Jatoi A, Loprinzi CL. Nutritional determinants of survival among patients with breast cancer. Surg Clin North Am. 1999 Oct; 79(5):1145-56.
    View PubMed
  164. Jatoi A, Daly BD, Hughes V, Dallal GE, Roubenoff R. The prognostic effect of increased resting energy expenditure prior to treatment for lung cancer. Lung Cancer. 1999 Feb; 23(2):153-8.
    View PubMed
  165. Jatoi A, Dallal GE, Nguyen PL. False-negative rates of tumor metastases in the histologic examination of bone marrow. Mod Pathol. 1999 Jan; 12(1):29-32.
    View PubMed
  166. Jatoi A, Nguyen PL. Can pathology residents be taught to perform adequate bone marrow biopsies? Acad Med. 1999; 74(4):452.
    View PubMed
  167. Jatoi A, Garcia-Moliner ML, Daly BD. Parosteal osteosarcoma from a rib. Ann Thorac Surg. 1998; 65(1):265-7.
    View PubMed
  168. Camilo ME, Jatoi A, O'Brien M, Davidson K, Sokoll L, Sadowski JA, Mason JB. Bioavailability of phylloquinone from an intravenous lipid emulsion. Am J Clin Nutr. 1998; 67(4):716-21.
    View PubMed
  169. Jatoi A, Daly BD, Kramer G, Mason JB. A cross-sectional study of vitamin intake in post-operative non-small cell lung cancer patients. J Surg Oncol. 1998; 68(4):231-6.
    View PubMed
  170. Jatoi A, Lennon C, O'Brien M, Sadowski J, Mason JB. Protein-calorie malnutrition does not predict subtle vitamin K pepletion in hospitalized patients. Eur J Clinl Nutr. 1998; 52:934-7.
  171. Jatoi A, Jaromin R, Jennings L, Nguyen PL. Using the absolute neutrophil count as a stand-alone test in a hematology/oncology clinic: an abbreviated test can be preferable. Clin Lab Manage Rev. 1998; 12(4):256-60.
    View PubMed
  172. Jatoi A, Hanjosten K, Ross E, Mason JB. A prospective survey for central line skin-site colonization by the pathogen malassezia furfur among hospitalized adults receiving total parenteral nutrition. JPEN. 1997; 21(4):230-2.
  173. Jatoi A, Jaromin R, Gryzbek D, Nguyen PL. Surveying technologists: a novel method for establishing productivity standards in a clinical hematology laboratory. Health Manpower Management. 1997; 23(45):167-9.
    View PubMed
  174. Ward JC, Gitlin JB, Garry DJ, Jatoi A, Luikart SD, Zelickson BD, Dahl MV, Skubitz KM. Epidermolysis bullosa acquisita induced by GM-CSF: a role for eosinophils in treatment-related toxicity. Br J Haematol. 1992 May; 81(1):27-32.
    View PubMed
  175. Massouh M, Jatoi A, Gordon EM, Ratnoff OD. Heparin co-factor II activity in plasma during pregnancy and oral contraceptive use. J Lab Clin Med. 1989; 114(6):697-9.
    View PubMed


Appointments | Contact Us | Give to Mayo Clinic | Search

LEGAL RESTRICTIONS AND TERMS OF USE APPLICABLE TO THIS SITE

Use of this site signifies your agreement to the terms of use.
© 2013 Mayo Foundation for Medical Education and Research. All rights reserved.